Internal Medicine, Nephrology · Montebello, CA
NPI
1891722369
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3114 W Beverly Blvd
Montebello, CA, 90640
Phone (323) 726-3868
Groups this clinician bills Medicare through
Medicare paid, 2024
$222K
1,672 services
Medicare patients, 2024
514
Average age 71
Drug cost, 2024
$1.2M
2,597 prescriptions
Company payments, 2025
$1,472
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos R Gonzalez was code 99233 (hospital e&m - subsequent), 537 times for 238 patients. In total Carlos R Gonzalez billed 1,672 services in 27 codes, and Medicare paid $222K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 537 | 238 | $98.47 | $53K |
| 90960 ESRD Related Services (not dialysis) | Office | 202 | 103 | $287.59 | $58K |
| 99223 Hospital E&M - Initial | Facility | 168 | 161 | $142.23 | $24K |
| 99291 Critical Care E&M | Facility | 117 | 46 | $174.43 | $20K |
| 99215 Office E&M - Established | Office | 110 | 54 | $130.97 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 108 | 55 | $65.53 | $7,077 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 91 | 53 | $12.24 | $1,114 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 80 | 20 | $54.21 | $4,337 |
| 90961 ESRD Related Services (not dialysis) | Office | 65 | 48 | $241.10 | $16K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 42 | 20 | $41.82 | $1,757 |
| 99222 Hospital E&M - Initial | Facility | 19 | 16 | $108.06 | $2,053 |
| 90935 Hemodialysis | Facility | 17 | 14 | $58.67 | $997 |
By year: 2022 $200K for 1,331 services; 2023 $234K for 1,665 services; 2024 $222K for 1,672 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos R Gonzalez prescribed most often to Medicare patients was Kerendia (Finerenone), with 471 prescriptions and refills. In total Carlos R Gonzalez wrote 2,597 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kerendia Finerenone | 471 | 518 | 64 | $313K |
| Farxiga Dapagliflozin Propanediol | 229 | 272 | 60 | $147K |
| Lokelma Sodium Zirconium Cyclosilicate | 181 | 217 | 34 | $162K |
| Dapagliflozin Dapagliflozin Propanediol | 138 | 152 | 29 | $74K |
| Furosemide Generic | 136 | 308 | 42 | $888 |
| Lisinopril Generic | 120 | 250 | 26 | $734 |
| Sevelamer Carbonate Generic | 80 | 143 | 23 | $13K |
| Calcitriol Generic | 62 | 122 | 14 | $1,008 |
| Veltassa Patiromer Calcium Sorbitex | 61 | 69 | 11 | $68K |
| Velphoro Sucroferric Oxyhydroxide | 60 | 86 | 11 | $186K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 52 | 52 | 32 | $309 |
| Carvedilol Generic | 46 | 73 | 11 | $226 |
| Allopurinol Generic | 44 | 81 | 13 | $299 |
| Atorvastatin Calcium Generic | 44 | 104 | Under 11 | $224 |
| Gentamicin Sulfate Generic | 43 | 43 | 16 | $1,502 |
Brand drugs: 1,424 claims; generic drugs: 1,152 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos R Gonzalez $1,472 ($1,472 in general payments such as food, travel and fees) from 17 companies. The largest payer was ANI Pharmaceuticals, Inc. with $223.
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. ANIP | 13 | $223 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $216 |
| GlaxoSmithKline, LLC. GSK | 8 | $184 |
| Calliditas Therapeutics US Inc. | 6 | $164 |
| Amgen Inc. AMGN | 7 | $138 |
| Travere Therapeutics, Inc. TVTX | 8 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $96.9 |
| Akebia Therapeutics Inc AKBA | 2 | $57.12 |
| Scpharmaceuticals Inc. SCPH | 2 | $52.4 |
| Fresenius USA Marketing, Inc. | 2 | $48.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.